Quality of life in total fundoplication surgery versus partial fundoplication in patients with gastroesophageal reflux disease
Abstract
Background: Gastroesophageal reflux disease (GERD) is a chronic disease with a prevalence of 20%, which has increased in recent years with complications such as Barrett's esophagus and risk of esophageal adenocarcinoma. Therefore, its medical and surgical treatment is crucial for the prognosis.
Methods: A retrospective cohort study of quality of life using the GERD questionnaire (GERDQ) was performed in patients with GERD who received surgical treatment with one-year postoperative follow-up at a tertiary care hospital in 2023. Patients were divided into two groups based on treatment: total fundoplication (group A) and partial fundoplication (group B). Statistical analysis included percentages, means, standard deviations, and group comparisons using the Chi-square test.
Results: Of the 35 patients, the mean age was 53.71±11.26 years, more frequent in women (54.30%). Typical symptoms were presented in 85.70% of cases, with persistence of these in 68.60%, indicating surgery, with symptoms lasting 122±68.88 days. The most frequent comorbidities were obesity and diabetes (22.90%). 54.30% underwent total fundoplication (group A) and 45.70% underwent partial fundoplication (group B). A low probability of presenting GERD after surgery was 78.90% in group A versus 75% in group B.
Conclusions: The quality of life is good in patients with GERD after surgical treatment, both with total fundoplication and partial fundoplication, obtaining a low probability of presenting GERD in both…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 35 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.